Bavarian Nordic AS operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bavarian Nordic AS with three other
pharmaceutical manufacturers in Europe:
Horizon Discovery Group PLC
of UNITED KINGDOM
sales of £58.25 million [US$76.05 million]
of which 57%
was Research Reagents),
Bonesupport Holding AB
(155.46 million Swedish Kronor [US$17.75 million]
of which 52%
was CERAMENT BVF), and
based in SPAIN
(22.81 million Euros [US$26.77 million]
of which 96%
was Product Sales).
Bavarian Nordic AS reported sales of 662.49 million Danish Kroner (US$104.43 million)
December of 2019.
increase of 32.3%
versus 2018, when the company's sales were 500.62 million Danish Kroner.
Despite this increase, sales are still
below the level achieved in 2017, when Bavarian Nordic AS
reported sales of 1.37 billion Danish Kroner.